Illumina, Inc.

137,32 USD -1,36 (-0,98%)
Bid 137,30 USD
Ask 140,00 USD

Premiumpartner

Firmenbeschreibung

Illumina, Inc. ist ein US-amerikanisches Unternehmen, das im Bereich Genforschung tätig ist. Die Kernkompetenzen des Konzerns liegen auf der Entwicklung, Herstellung und Vermarktung von Life Science-Geräten und integrierten Systemen für die Analyse von genetischen Variationen und Funktionen. In diesem Zusammenhang werden innovative Sequenzierungs- und Array-basierte Lösungen für Genotypisierung, Variationsanalyse, Methylierung sowie Genprofilierung und DNA-, RNA- und Protein-Untersuchung in Studien zur Verfügung gestellt. Darüber hinaus enthält das Leistungsspektrum auch Services und Hilfsmittel im Bereich Genomik und Diagnostik. Dabei kommen die Lösungen und Produkte der Gesellschaft in vielfältigen Bereichen wie beispielsweise bei Pharma- und Biotechnologieunternehmen wie auch bei Regierungs- und Bildungsbehörden weltweit zum Einsatz. Im Wesentlichen dienen die Produkte und Technologien von Illumina der Erforschung von Genmaterial sowie einer schnellen Analyse und ebnen den Weg für molekulare Medizin. Nicht zuletzt werden durch DNA- und Protein-Analysen Fortschritte in der Erforschung von Krankheiten, Medikamenten und molekularen klinischen Tests ermöglicht.

KeyData

endOfFinancialYear: 31.12.2022 00:00
stockholderStructure: Vanguard Group Inc (9.87%),Baillie Gifford and Company (8.83%),Blackrock Inc. (8.51%),Morgan Stanley (4.77%),State Street Corporation (4.24%),Edgewood Management Llc (3.52%),Wellington Management Group, LLP (3.33%),Polen Capital Management, LLC (3.22%),Janus Henderson Group PLC (3.02%),Loomis Sayles & Company, LP (2.4%)
sharesOutstanding: 158900000.0000
ceo: Charles Dadswell
board: Joydeep Goswami, Steve Barnard, Nicole Berry, Aimee Hoyt, Kevin Pegels, Li Qing, Kathryne Reeves, Carissa Rollins, Salli Schwartz, Susan Tousi, Bas Verhoef, Gretchen Weightman
supervisoryBoard: Stephen P. MacMillan, Frances Arnold, PhD, Caroline Dorsa, Robert S. Epstein, Scott Gottlieb, Gary S. Guthart, Philip Schiller, Sue Siegel, Andrew Teno, Scott B. Ullem
countryID: 20
freeFloat: 48.2900
faceValue: 0.0100
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Medizintechnische Produkte
industryName: Gesundheitswesen
subsectorName: Hochentwickelte medizinische Geräte
country: USA
countryName: USA

Kontakt

phone: +1-858-291-6421
email: ir@illumina.com
irWebSite: https://investor.illumina.com/investors/default.aspx

Adresse

street: 5200 Illumina Way
city: San Diego, California 92122, USA
phone: +1-858-202-4500
fax: +1-858-202-4766
webSite: www.illumina.com/
email: info@illumina.com

Finanzen (kurz)

year: 2021 cash: 1232.0000
balanceSheetTotal: 15217.0000 liabilities: 4477.0000
shareCapital: 2.0000 totalShareholdersEquity: 10740.0000
sales: 4526.0000 bankLoans: -123.0000
investment: 0.0000 incomeBeforeTaxes: 884.0000
netIncome: 762.0000 cashFlow: -578.0000
employees: 9100 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 2011.0000
balanceSheetTotal: 12252.0000 liabilities: 5653.0000
shareCapital: 2.0000 totalShareholdersEquity: 6599.0000
sales: 4584.0000 incomeBeforeTaxes: -4336.0000
netIncome: -4404.0000 cashFlow: 779.0000
currencyID: 4 units: 1000000
currency: USD
year: 2023 cash: 1048.0000
balanceSheetTotal: 10111.0000 liabilities: 4366.0000
shareCapital: 2.0000 totalShareholdersEquity: 5745.0000
sales: 4504.0000 incomeBeforeTaxes: -1117.0000
netIncome: -1161.0000 cashFlow: -963.0000
currencyID: 4 units: 1000000
currency: USD

Finanzen (kurz)

year: 2021
cash: 1232.0000
balanceSheetTotal: 15217.0000
liabilities: 4477.0000
shareCapital: 2.0000
totalShareholdersEquity: 10740.0000
sales: 4526.0000
bankLoans: -123.0000
investment: 0.0000
incomeBeforeTaxes: 884.0000
netIncome: 762.0000
cashFlow: -578.0000
employees: 9100
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 2011.0000
balanceSheetTotal: 12252.0000
liabilities: 5653.0000
shareCapital: 2.0000
totalShareholdersEquity: 6599.0000
sales: 4584.0000
incomeBeforeTaxes: -4336.0000
netIncome: -4404.0000
cashFlow: 779.0000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 1048.0000
balanceSheetTotal: 10111.0000
liabilities: 4366.0000
shareCapital: 2.0000
totalShareholdersEquity: 5745.0000
sales: 4504.0000
incomeBeforeTaxes: -1117.0000
netIncome: -1161.0000
cashFlow: -963.0000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 12252.0000 cash: 2011.0000
currentAssets: 3561.0000 fixedAssets: 8691.0000
liabilities: 2773.0000 totalLiabilitiesEquity: 12252.0000
totalShareholdersEquity: 6599.0000 property: 1091.0000
intangibleAssets: 3285.0000 inventories: 568.0000
accountsReceivable: 671.0000 accountsPayable: 293.0000
liabilitiesTotal: 5653.0000 longTermDebt: 1487.0000
shortTermDebt: 748.0000 commonStock: 2.0000
preferredStock: 0.0000 sales: 4584.0000
netIncome: -4404.0000 operatingResult: -4179.0000
incomeInterest: 15.0000 investments: 1321.0000
incomeTaxes: 68.0000 costGoodsSold: 1612.0000
grossProfit: 2972.0000 cashFlow: 392.0000
cashFlowInvesting: -591.0000 cashFlowFinancing: 1000.0000
cashFlowTotal: 779.0000 accountingStandard: US GAAP
equityRatio: 53.8606 debtEquityRatio: 85.6645
liquidityI: 72.5207 liquidityII: 96.7184
netMargin: -96.0733 grossMargin: 64.8342
cashFlowMargin: 8.5515 ebitMargin: -91.1649
ebitdaMargin: 0.0000 preTaxROE: -65.7069
preTaxROA: -35.3901 roe: -66.7374
roa: -35.9452 netIncomeGrowth: -677.9528
revenuesGrowth: 1.2815 taxExpenseRate: -1.5683
equityTurnover: 0.6947 epsBasic: -28.0000
epsDiluted: -28.0000 epsBasicGrowth: -652.2682
shareCapital: 2.0000 incomeBeforeTaxes: -4336.0000
priceCashFlowRatio: 81.4990 bookValuePerShare: 41.7658
marketCap: 31947600000.0000 earningsYield: -13.8477
cashFlowPerShare: 2.4810 priceBookValueRatio: 4.8413
netEarningsPerShare: -27.8734 currency: USD
year: 2023 units: 1000000
balanceSheetTotal: 10111.0000 cash: 1048.0000
currentAssets: 2609.0000 fixedAssets: 7502.0000
liabilities: 1570.0000 totalLiabilitiesEquity: 10111.0000
totalShareholdersEquity: 5745.0000 property: 1007.0000
intangibleAssets: 2993.0000 inventories: 587.0000
accountsReceivable: 734.0000 accountsPayable: 245.0000
liabilitiesTotal: 4366.0000 longTermDebt: 1489.0000
shortTermDebt: 0.0000 commonStock: 2.0000
preferredStock: 0.0000 sales: 4504.0000
netIncome: -1161.0000 operatingResult: -1069.0000
incomeInterest: 19.0000 investments: 1354.0000
incomeTaxes: 44.0000 costGoodsSold: 1760.0000
grossProfit: 2744.0000 cashFlow: 478.0000
cashFlowInvesting: -231.0000 cashFlowFinancing: -1210.0000
cashFlowTotal: -963.0000 accountingStandard: US GAAP
equityRatio: 56.8193 debtEquityRatio: 75.9965
liquidityI: 66.7516 liquidityII: 113.5032
netMargin: -25.7771 grossMargin: 60.9236
cashFlowMargin: 10.6128 ebitMargin: -23.7345
ebitdaMargin: 0.0000 preTaxROE: -19.4430
preTaxROA: -11.0474 roe: -20.2089
roa: -11.4825 netIncomeGrowth: -73.6376
revenuesGrowth: -1.7452 taxExpenseRate: -3.9391
equityTurnover: 0.7840 epsBasic: -7.3400
epsDiluted: -7.3400 epsBasicGrowth: -73.7857
shareCapital: 2.0000 incomeBeforeTaxes: -1117.0000
priceCashFlowRatio: 46.2871 bookValuePerShare: 36.1548
marketCap: 22125236000.0000 earningsYield: -5.2715
cashFlowPerShare: 3.0082 priceBookValueRatio: 3.8512
netEarningsPerShare: -7.3065 currency: USD
year: 2024 priceCashFlowRatio: 45.6488
bookValuePerShare: 36.1548 marketCap: 21820148000.0000
earningsYield: -5.3452 pegRatio: 0.2536
cashFlowPerShare: 3.0082 netAssetsPerShare: 36.1548
priceBookValueRatio: 3.7981 netEarningsPerShare: -7.3065
currency: USD

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 12252.0000
cash: 2011.0000
currentAssets: 3561.0000
fixedAssets: 8691.0000
liabilities: 2773.0000
totalLiabilitiesEquity: 12252.0000
totalShareholdersEquity: 6599.0000
property: 1091.0000
intangibleAssets: 3285.0000
inventories: 568.0000
accountsReceivable: 671.0000
accountsPayable: 293.0000
liabilitiesTotal: 5653.0000
longTermDebt: 1487.0000
shortTermDebt: 748.0000
commonStock: 2.0000
preferredStock: 0.0000
sales: 4584.0000
netIncome: -4404.0000
operatingResult: -4179.0000
incomeInterest: 15.0000
investments: 1321.0000
incomeTaxes: 68.0000
costGoodsSold: 1612.0000
grossProfit: 2972.0000
cashFlow: 392.0000
cashFlowInvesting: -591.0000
cashFlowFinancing: 1000.0000
cashFlowTotal: 779.0000
accountingStandard: US GAAP
equityRatio: 53.8606
debtEquityRatio: 85.6645
liquidityI: 72.5207
liquidityII: 96.7184
netMargin: -96.0733
grossMargin: 64.8342
cashFlowMargin: 8.5515
ebitMargin: -91.1649
ebitdaMargin: 0.0000
preTaxROE: -65.7069
preTaxROA: -35.3901
roe: -66.7374
roa: -35.9452
netIncomeGrowth: -677.9528
revenuesGrowth: 1.2815
taxExpenseRate: -1.5683
equityTurnover: 0.6947
epsBasic: -28.0000
epsDiluted: -28.0000
epsBasicGrowth: -652.2682
shareCapital: 2.0000
incomeBeforeTaxes: -4336.0000
priceCashFlowRatio: 81.4990
bookValuePerShare: 41.7658
marketCap: 31947600000.0000
earningsYield: -13.8477
cashFlowPerShare: 2.4810
priceBookValueRatio: 4.8413
netEarningsPerShare: -27.8734
currency: USD
year: 2023
units: 1000000
balanceSheetTotal: 10111.0000
cash: 1048.0000
currentAssets: 2609.0000
fixedAssets: 7502.0000
liabilities: 1570.0000
totalLiabilitiesEquity: 10111.0000
totalShareholdersEquity: 5745.0000
property: 1007.0000
intangibleAssets: 2993.0000
inventories: 587.0000
accountsReceivable: 734.0000
accountsPayable: 245.0000
liabilitiesTotal: 4366.0000
longTermDebt: 1489.0000
shortTermDebt: 0.0000
commonStock: 2.0000
preferredStock: 0.0000
sales: 4504.0000
netIncome: -1161.0000
operatingResult: -1069.0000
incomeInterest: 19.0000
investments: 1354.0000
incomeTaxes: 44.0000
costGoodsSold: 1760.0000
grossProfit: 2744.0000
cashFlow: 478.0000
cashFlowInvesting: -231.0000
cashFlowFinancing: -1210.0000
cashFlowTotal: -963.0000
accountingStandard: US GAAP
equityRatio: 56.8193
debtEquityRatio: 75.9965
liquidityI: 66.7516
liquidityII: 113.5032
netMargin: -25.7771
grossMargin: 60.9236
cashFlowMargin: 10.6128
ebitMargin: -23.7345
ebitdaMargin: 0.0000
preTaxROE: -19.4430
preTaxROA: -11.0474
roe: -20.2089
roa: -11.4825
netIncomeGrowth: -73.6376
revenuesGrowth: -1.7452
taxExpenseRate: -3.9391
equityTurnover: 0.7840
epsBasic: -7.3400
epsDiluted: -7.3400
epsBasicGrowth: -73.7857
shareCapital: 2.0000
incomeBeforeTaxes: -1117.0000
priceCashFlowRatio: 46.2871
bookValuePerShare: 36.1548
marketCap: 22125236000.0000
earningsYield: -5.2715
cashFlowPerShare: 3.0082
priceBookValueRatio: 3.8512
netEarningsPerShare: -7.3065
currency: USD
year: 2024
priceCashFlowRatio: 45.6488
bookValuePerShare: 36.1548
marketCap: 21820148000.0000
earningsYield: -5.3452
pegRatio: 0.2536
cashFlowPerShare: 3.0082
netAssetsPerShare: 36.1548
priceBookValueRatio: 3.7981
netEarningsPerShare: -7.3065
currency: USD